Eyepoint Pharmaceuticals, Inc. (EYPT) SEC Filings — 2024

Filings

• EyePoint Pharmaceuticals Files 8-K — 8-K · Dec 4, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 7, 2024
• EyePoint Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 6, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• EyePoint Pharmaceuticals Enters Material Definitive Agreement — 8-K · Oct 31, 2024
• Eyepoint Pharmaceuticals, Inc. 8-K Filing — 8-K · Oct 28, 2024
• EyePoint Pharmaceuticals to be Acquired for $1.4 Billion — 8-K · Oct 24, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
• EyePoint Pharma Appoints Dr. Guyer CEO, Miller Departs Board — 8-K · Sep 4, 2024
• EyePoint Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• EyePoint Pharmaceuticals Files 8-K on Financials — 8-K · Aug 7, 2024
• EyePoint Pharmaceuticals Files 8-K — 8-K · Jun 26, 2024
• EyePoint Pharmaceuticals Announces Board and CFO Changes — 8-K · Jun 21, 2024
• Eyepoint Pharmaceuticals, Inc. 8-K Filing — 8-K · May 28, 2024
• EyePoint Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• EyePoint Pharmaceuticals Files 8-K on Financials — 8-K · May 8, 2024
• Eyepoint Pharmaceuticals, Inc. 8-K Filing — 8-K · May 6, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · May 1, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Apr 30, 2024
• EyePoint Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Apr 26, 2024
• EyePoint Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 8, 2024
• EyePoint Pharmaceuticals Files 8-K on Financials — 8-K · Mar 7, 2024
• EyePoint Pharmaceuticals Files 8-K — 8-K · Mar 4, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Eyepoint Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Adage Capital Amends EyePoint Pharma Stake as of Dec 31, 2023 — SC 13G/A · Feb 7, 2024
• Franklin Resources Amends EyePoint Pharma Stake (SC 13G/A) — SC 13G/A · Feb 6, 2024
• EyePoint Pharma Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 10, 2024